Prevalence and Clinical Significance of CSF Alzheimer's Disease Biomarkers in People With Versus Without HIV

This seminar explores the prevalence and clinical significance of cerebrospinal fluid (CSF) Alzheimer's disease biomarkers in people with versus without HIV. Presented by Dr. Erin Sundermann and Lilly Ham from the University of California, San Diego, the 51-minute talk delves into the intersection of HIV and Alzheimer's disease research. Learn about how these biomarkers differ between HIV-positive and HIV-negative individuals, and understand their implications for diagnosis, treatment, and long-term care. The presentation is part of the Johns Hopkins Medicine seminar series focused on neuroHIV research, providing valuable insights for healthcare professionals, researchers, and those interested in the neurological complications of HIV infection.